Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Medtronic spends $200 million to acquire disease management company Cardiocom, the Wall Street Journal reports. Medtronic (NYSE:MDT) bought Cardiocom LLC for $200 million in cash in a bid to get into the disease management business, according to the Wall Street Journal. Chanhassen, Minn.-based Cardiocom makes devices aimed at helping to manage chronic conditions like diabetes or heart disease. The acquisition is aimed at putting Fridley, Minn.-based Medtronic in position to take advantage of the increasing focus on lowering healthcare costs, Medtronic's U.S. president Mike Genau told the newspaper.
Help employers find you! Check out all the jobs and post your resume.
Medtronic spends $200 million to acquire disease management company Cardiocom, the Wall Street Journal reports. Medtronic (NYSE:MDT) bought Cardiocom LLC for $200 million in cash in a bid to get into the disease management business, according to the Wall Street Journal. Chanhassen, Minn.-based Cardiocom makes devices aimed at helping to manage chronic conditions like diabetes or heart disease. The acquisition is aimed at putting Fridley, Minn.-based Medtronic in position to take advantage of the increasing focus on lowering healthcare costs, Medtronic's U.S. president Mike Genau told the newspaper.
Help employers find you! Check out all the jobs and post your resume.
